000597 東北製藥
按盤價 
4.750 +0.090 (+1.931%)
4.750 +0.090 (+1.931%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.147 | 7.509 | 8.049 | 2.438 | 0.310 |
| 總資產報酬率 ROA (%) | 0.373 | 2.465 | 2.595 | 0.781 | 0.099 |
| 投入資產回報率 ROIC (%) | 0.478 | 3.305 | 3.570 | 1.051 | 0.138 | 邊際利潤分析 |
| 銷售毛利率 (%) | 38.188 | 40.676 | 38.955 | 39.486 | 39.160 |
| 營業利潤率 (%) | 6.065 | 6.044 | 7.905 | 2.300 | 2.074 |
| 息稅前利潤/營業總收入 (%) | 5.700 | 5.559 | 6.055 | 2.890 | 2.685 |
| 淨利潤/營業總收入 (%) | 3.081 | 4.561 | 4.054 | 1.172 | 0.147 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.074 | 118.584 | 71.086 | 145.325 | 158.427 |
| 價值變動淨收益/利潤總額(%) | 1.952 | 1.763 | 0.000 | 45.209 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -1.060 | -2.059 | -32.528 | -55.913 | -66.761 | 償債能力分析 |
| 流動比率 (X) | 1.034 | 1.022 | 0.942 | 0.829 | 0.759 |
| 速動比率 (X) | 0.890 | 0.880 | 0.797 | 0.677 | 0.588 |
| 資產負債率 (%) | 66.477 | 66.225 | 65.871 | 67.447 | 66.116 |
| 帶息債務/全部投入資本 (%) | 55.361 | 54.847 | 48.864 | 52.969 | -- |
| 股東權益/帶息債務 (%) | 74.991 | 76.265 | 95.515 | 79.390 | 88.722 |
| 股東權益/負債合計 (%) | 48.765 | 49.316 | 50.119 | 46.615 | 49.489 |
| 利息保障倍數 (X) | -18.939 | -15.287 | 67.412 | 2.043 | 1.863 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 88.852 | 82.734 | 78.069 | 78.689 | 0.000 |
| 存貨周轉天數 (天) | 104.955 | 95.131 | 82.602 | 91.316 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/04/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
